• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join
  2. →
  3. → Articles

features


Newsletter

Oct 08 2018 06:43 PM | ImmInst in LongeCity

The LongeCity newsletter is usually send out on the 8th/18th day of each month to Members and registered forum users.

To subscribe or unsubscribe: Visit this link and check if the box for 'Send me any updates sent by the board administrator' is...

Read story →    1 comments    *****

Aging Biomarker Testing Support Programme

Jun 08 2018 07:32 PM | ImmInst in LongeCity

Background

LongeCity.org has long been a hotbed of information exchange and discussion about various methods of slowing or reversing the process of aging. An incredible number of supplements have been tried, exercise routines employed, and e...

Read story →    0 comments    -----

Cryonics

May 01 2018 09:52 PM | benbest in Articles

The following is a quick overview on Cryonics.


NB: The information below is periodically reviewed for accuracy, but LongeCity makes no representations or gives any warranties whatsoever that the following information is accurate and complet...

Read story →    0 comments    *****


Write for LongeCity

Apr 28 2018 05:20 PM | caliban in LongeCity

There are different ways of writing for LongeCity, in two basic categories: Content and Articles
All contributions are subject to the general LongeCity User agreement. In short: authors keep full copyright of the article, but grant a free perpetu...

Read story →    0 comments    -----

Aging Theories: is an 'aging program' a...

Apr 18 2018 05:45 PM | ImmInst in Articles

by Theodore C. Goldsmith



Read story →    1 comments    -----


LongeCity Connect

Apr 01 2018 04:56 PM | caliban in LongeCity

Database of Experts, Advocates and Volunteers  
LongeCity has been 'the' forum for information exchange on life extension for over a decade. Over the years, many of the 'who is who' in the scene have visited the site,...

Read story →    0 comments    *****

Antioxidants- relevant for life extension?

Feb 18 2018 11:29 PM | yoik in Articles

by Vit Zemanek



Read story →    0 comments    ****-


About

Jan 08 2018 11:16 PM | ImmInst in LongeCity

The LongeCity (Longecity.org/ImmInst.org) is an international, not-for-profit, membership-based organization 

Our mission is "to conquer the blight of involuntary death".
To advance this mission, we aim to foster:

...

Read story →    2 comments    *****

'₮hank You' points explained

Jan 07 2018 11:14 PM | ThankYou in LongeCity

All registered users can earn '₮hank You' ('₮') points:
By getting positive 'reputation' votes, or by getting direct 'donations' from other members (anyone can donate by clicking on their ₮ count underneath their avatar/portra...

Read story →    0 comments    *****


Nootropics in human trials (Intro)

Sep 09 2017 12:15 PM | lukas_93 in Articles

by Lukas

 

Due to further advances in the field of neuropharmacology new possibilities of cognitive self-enhancement emerge.
Some are marketed as ‘smart drugs’, cognitive enhancers or nootropics.

 

This article aims to provide a brief overview.



Read story →    0 comments    ****-

Aging theories: Is there a unifying factor in a...

Aug 20 2017 05:40 PM | ImmInst in Articles

by: Vit Zemanek

 

- evolutionary approach to the process of senescence
- programmed theories of aging
- error theories of aging



Read story →    1 comments    -----


Geroprotector Review: Rapamycin and other mTOR...

Jul 18 2017 08:59 PM | s123 in Articles

Sven Bulterijs continues his discussion of prominent compounds with potential life extension efficacy by looking not just at rapamycin but also at its target, the mTOR pathway, which has likely a key role in mediating lifespan. ⇒ read the article i...

Read story →    0 comments    -----

Metformin - a geroprotector?

May 19 2017 07:09 PM | s123 in Articles

Sven Bulterijs first discussed the potential utility of anti-diabetic substance metformin six years ago on LongeCity. Now Sven returns to the topic with a comprehensive and thoughtful discussion of the recent findings and further background information...

Read story →    0 comments    -----


Next Page »


Search Articles
  1. LONGECITY
  2. → Portal
  3. → Articles
  4. Forum Rules